These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15742456)

  • 1. Mechanism of action of tumor necrosis factor antagonists. Proceedings of the Canadian expert roundtable meeting, Banff, Canada, November 28-30, 2003.
    J Rheumatol Suppl; 2005 Mar; 74():1-47. PubMed ID: 15742456
    [No Abstract]   [Full Text] [Related]  

  • 2. TNF antagonists and shingles: is vaccination advisable?
    Nisar MK; Ostor AJ
    Ann Rheum Dis; 2013 May; 72(5):e1. PubMed ID: 23456927
    [No Abstract]   [Full Text] [Related]  

  • 3. Is there a rationale for switching from one anti-tumor necrosis factor agent to another?
    Haraoui B
    J Rheumatol; 2004 Jun; 31(6):1021-2. PubMed ID: 15170907
    [No Abstract]   [Full Text] [Related]  

  • 4. Setting the research agenda for future clinical trials on the use of biologics in rheumatology.
    Silman A; Rudkin S; Walley T
    Rheumatology (Oxford); 2011 Aug; 50(8):1356-7. PubMed ID: 21118870
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of TNF alpha inhibitors in rheumatology: many questions, enough answers?
    Wendling D; Verhoeven F; Guillot X; Prati C
    Expert Opin Drug Saf; 2017 Jan; 16(1):1-3. PubMed ID: 27737601
    [No Abstract]   [Full Text] [Related]  

  • 6. Introduction to special section: biologic agents in the treatment of rheumatic diseases-the first decade.
    Yelin E; Katz P
    Arthritis Rheum; 2009 May; 61(5):559. PubMed ID: 19405010
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-adalimumab antibodies in paediatric rheumatology patients: a pilot experience.
    Murias S; Alcobendas R; Pascual-Salcedo D; Remesal A; Peralta J; Merino R
    Rheumatology (Oxford); 2014 Nov; 53(11):2124-6. PubMed ID: 25102859
    [No Abstract]   [Full Text] [Related]  

  • 8. [TNF-alpha antagonists in therapy of rheumatoid arthritis].
    Gross WL; Gause A
    Z Rheumatol; 2003 Jun; 62(3):217. PubMed ID: 12931691
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings from the XIth International Symposium on Advances in Targeted Therapies, 22 to 26 April 2009.
    Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i1-99. PubMed ID: 20310079
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on prescribing tumor necrosis factor inhibitors.
    Hanauer LB
    Arthritis Rheum; 2002 Jun; 47(3):347-8. PubMed ID: 12115169
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha blocker induced tuberculosis.
    Kharbanda P; Dagaonkar R; Balakrishnan C; Udwadia ZF
    J Rheumatol; 2010 Jul; 37(7):1542; author reply 1543. PubMed ID: 20595292
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biological treatment of rhematoid diseases].
    Pavelka K
    Vnitr Lek; 2006 Jun; 52(6):561-2. PubMed ID: 16871758
    [No Abstract]   [Full Text] [Related]  

  • 13. Was risk properly assessed in Carter, et al's safety assessment of tumor necrosis factor antagonists during pregnancy?
    Winger EE; Reed JL
    J Rheumatol; 2009 Sep; 36(9):2122; author reply 2123. PubMed ID: 19738224
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in Targeted Therapies VI. Proceedings of the 6th International Symposium. Venice, Italy, 28 April-2 May 2004.
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2():ii1-101. PubMed ID: 15479863
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pregnancy in rheumatic patients treated with biologic drugs].
    Sentić M; Baresić M; Anić B; Bosnić D; Cerovec M; Mayer M; Smiljanić L; Cikes N
    Lijec Vjesn; 2010; 132(9-10):317-8. PubMed ID: 21261033
    [No Abstract]   [Full Text] [Related]  

  • 16. Introduction.
    Cantini F
    Expert Opin Drug Saf; 2016 Dec; 15(sup1):1. PubMed ID: 27924647
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccine history knowledge of subcutaneous anti-TNF receiving rheumatology patients.
    Nolan TJ; O'Connor MB; Bond U; Swan J; Phelan MJ
    Rheumatol Int; 2013 Jul; 33(7):1907-8. PubMed ID: 22441967
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: the vital role of randomized controlled trials in Arthritis & Rheumatology.
    Solomon DH; Weinblatt ME; Bucala RJ
    Arthritis Rheumatol; 2015 Oct; 67(10):2555-6. PubMed ID: 26139424
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in targeted therapies X. Preface.
    Breedveld FC; Kalden JR; Smolen JS
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii1. PubMed ID: 19022807
    [No Abstract]   [Full Text] [Related]  

  • 20. The development of anticytokine therapeutics for rheumatic diseases.
    Arend WP; Goldring MB
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S102-9. PubMed ID: 18240200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.